Member Login

Immunotherapy Effective in Alveolar Soft Part Sarcoma

People with advanced alveolar soft part sarcoma (ASPS), a rare cancer, appear to benefit from a type of immunotherapy called an immune checkpoint inhibitor, according to results from a small clinical trial.